F-NEO-BRIGHT: feasibility and safety of intranasal fresh breast milk in neonatal encephalopathy

F-NEO -BRIGHT Study is the first clinical trial where intranasal fresh breast milk is administered to neonates with neonatal encephalopathy. Intranasal fresh breast milk administration during the first month of life appears to be feasible, safe and well-tolerated both in hospital and in the home settings. The full therapeutic potential of this treatment could be revealed by further research into long-term neurodevelopmental outcomes.